Sitravatinib

CAS : 1123837-84-2

Ref. 3D-BS166446

Informations sur le produit

• Nom: Sitravatinib
• Synonymes: MGCD516
• Marque: Biosynth
• Description: Inhibits multiple receptor tyrosine kinases (RTKs), including c-Kit, PDGFRβ, PDGFRα, c-Met, and Axl. Sitravatinib inhibits proliferation of sarcoma cells and reduced tumor growth in vivo. Promotes immune response in tumor microenvironment and enhances sensitivity to immune checkpoint inhibitors. This compound is undergoing several clinical trials as a potential anti-cancer therapeutic agent.

Propriétés chimiques

• Masse moléculaire: 629.68 g/mol
• Formule: C₃₃H₂₉F₂N₅O₄S
• Degré de pureté: Min. 95%
• Couleur/Forme: Solid
• InChI: InChI=1S/C33H29F2N5O4S/c1-43-15-14-36-18-20-2-8-25(38-19-20)29-17-26-30(45-29)28(10-13-37-26)44-27-9-7-23(16-24(27)35)40-32(42)33(11-12-33)31(41)39-22-5-3-21(34)4-6-22/h2-10,13,16-17,19,36H,11-12,14-15,18H2,1H3,(H,39,41)(H,40,42)
• Code InChI: InChIKey=WLAVZAAODLTUSW-UHFFFAOYSA-N
• SMILES: COCCNCc1ccc(-c2cc3nccc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)cc4F)c3s2)nc1